健麾信息(605186) - 2025 Q2 - 季度业绩预告

Summary of Performance Forecast The company projects a substantial decline in H1 2025 net profit attributable to shareholders and non-recurring net profit, with decreases exceeding 50% | Indicator | H1 2025 Forecast | H1 2024 Actual | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 5 million - 8 million yuan | 29.54 million yuan | ↓ 72.92% to 83.08% | | Non-recurring Net Profit Attributable to Shareholders | 4.8 million - 7.8 million yuan | 22.36 million yuan | ↓ 65.11% to 78.53% | Details of Current Period Performance Forecast This forecast covers H1 2025, with preliminary estimates projecting unaudited net profit attributable to shareholders between 5 million and 8 million yuan, and non-recurring net profit between 4.8 million and 7.8 million yuan | Project | H1 2025 Estimated Amount | Decrease Compared to Prior Year | Year-on-Year Decrease | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 5.00 million - 8.00 million yuan | 21.54 million - 24.54 million yuan | 72.92% - 83.08% | | Non-recurring Net Profit Attributable to Shareholders | 4.80 million - 7.80 million yuan | 14.56 million - 17.56 million yuan | 65.11% - 78.53% | - This performance forecast is based on the company's preliminary calculations and has not yet been audited by a certified public accountant[6] Review of Prior Period Performance The company disclosed key H1 2024 financial data for comparison, including net profit attributable to shareholders of 29.54 million yuan and non-recurring net profit of 22.36 million yuan | Indicator (Jan-Jun 2024) | Amount | | :--- | :--- | | Total Profit | 34.56 million yuan | | Net Profit Attributable to Shareholders | 29.54 million yuan | | Non-recurring Net Profit Attributable to Shareholders | 22.36 million yuan | | Earnings Per Share | 0.22 yuan | Analysis of Performance Changes Despite stable revenue growth (approximately 150 million to 160 million yuan) driven by core business recovery and overseas expansion, net profit significantly declined due to lower margins from new businesses and increased R&D investments - During the reporting period, the company's operating revenue maintained stable growth, estimated at approximately 150 million to 160 million yuan, primarily due to the recovery of core businesses and expansion into overseas markets (Saudi Arabia, Russia, Hong Kong, Taiwan, etc.)[9] - One primary reason for the profit decline is that emerging business segments, such as intelligent sterile compounding centers and logistics and mobile robots, are still in their incubation period, exhibiting lower profit margins compared to traditional businesses[9] - The company continues to increase R&D investment, focusing on new product development and technological upgrades like non-whole box packaging and 24-hour unmanned retail, which also impacted current period profit[9] - The company anticipates future profitability improvements with business structure optimization and enhanced operational efficiency[9] Risk Warning and Other Matters The company emphasizes this performance forecast is a preliminary, unaudited financial estimate, advising investors that final accurate data will be based on the officially disclosed 2025 semi-annual report - This performance forecast represents preliminary calculations by the company's finance department based on professional judgment and has not been audited by a certified public accountant[10] - The company reminds investors that specific and accurate financial data will be subject to the officially disclosed 2025 semi-annual report, urging caution regarding investment risks[12]